Home » Topics » BioWorld

BioWorld
RSS

SYNTRO-HOECHST ANIMAL VACCINE DEAL

Feb. 20, 1992

IVAX UNIT BEGINS ALZHEIMER'S TRIALS

Feb. 20, 1992

CHIMP STILL FREE OF AIDS INFECTION

Feb. 20, 1992

WALL ST. VENTS FRUSTRATION AT CENTOCOR

Feb. 20, 1992

EPITOPE TOLD TO EXPAND DISEASE TARGETS

Feb. 20, 1992

SANDOZ COMPLETES SYSTEMIX TENDER OFFER

Feb. 20, 1992

TAXOL MAKER CLOSES PRIVATE PLACEMENT

Feb. 20, 1992

PARKINSON'S TREATMENT DISAPPOINTING

Feb. 20, 1992

AMYLIN SPEEDS UP TRIAL PLANS

Feb. 19, 1992

NVX VACCINE DEAL WITH DANES

Feb. 19, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...